(Q39354418)

11 September 2017

title

Ziconotide infusion for severe chronic pain: case series of patients with neuropathic pain (English)

1 reference

11 September 2017

0 references

0 references

chronic neuropathic pain

0 references

author name string

Daniel P Wermeling

series ordinal

1

1 reference

11 September 2017

Joseph R Berger

series ordinal

2

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

11 September 2017

number of pages

8

1 reference

inferred from page(s)

published in

Pharmacotherapy

1 reference

11 September 2017

volume

26

1 reference

11 September 2017

issue

3

1 reference

11 September 2017

page(s)

395-402

1 reference

A new Conus peptide ligand for mammalian presynaptic Ca2+ channels

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.395

Binding of chimeric analogs of omega-conotoxin MVIIA and MVIIC to the N- and P/Q-type calcium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.395

Novel omega-conotoxins from Conus catus discriminate among neuronal calcium channel subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.395

Effect of continuous intrathecal infusion of omega-conopeptides, N-type calcium-channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.395

Ziconotide, an intrathecally administered N-type calcium channel antagonist for the treatment of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.395

Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.395

Use of intrathecal SNX-111, a novel, N-type, voltage-sensitive, calcium channel blocker, in the management of intractable brachial plexus avulsion pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.395

Long-term intrathecal ziconotide therapy: a case study and discussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.395

Ziconotide for the treatment of severe spasticity after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.395

Epidural opioid therapy for chronic nonmalignant pain: critique of current experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.395

Risks and benefits of long-term intrathecal analgesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.395

Sympatholysis after neuron-specific, N-type, voltage-sensitive calcium channel blockade: first demonstration of N-channel function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.395

Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery-- report of an expert panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.395

21 January 2018

Identifiers

DOI

10.1592/PHCO.26.3.395

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/c2db5xdvmnfqtbbxrjpfec4kpi

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_c2db5xdvmnfqtbbxrjpfec4kpi

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/c2db5xdvmnfqtbbxrjpfec4kpi

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/c2db5xdvmnfqtbbxrjpfec4kpi

1 reference

30 July 2022